Charilaos Filippakis, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pinocytosis | 3 | 2021 | 84 | 2.490 |
Why?
|
Lymphangioleiomyomatosis | 5 | 2021 | 230 | 1.800 |
Why?
|
Tuberous Sclerosis | 3 | 2021 | 995 | 1.290 |
Why?
|
Lysosomes | 4 | 2021 | 927 | 0.920 |
Why?
|
Ritanserin | 1 | 2021 | 12 | 0.910 |
Why?
|
Diacylglycerol Kinase | 1 | 2021 | 47 | 0.890 |
Why?
|
Class III Phosphatidylinositol 3-Kinases | 1 | 2018 | 20 | 0.760 |
Why?
|
Receptors, LDL | 1 | 2017 | 539 | 0.540 |
Why?
|
Herpesviridae | 1 | 2010 | 107 | 0.400 |
Why?
|
Cholesterol | 1 | 2017 | 2751 | 0.350 |
Why?
|
Genes, ras | 1 | 2011 | 728 | 0.350 |
Why?
|
Cytomegalovirus | 1 | 2011 | 656 | 0.340 |
Why?
|
Autophagy | 3 | 2021 | 1267 | 0.310 |
Why?
|
Membrane Glycoproteins | 1 | 2017 | 3853 | 0.300 |
Why?
|
ras Proteins | 1 | 2010 | 1141 | 0.270 |
Why?
|
Carrier Proteins | 1 | 2017 | 5257 | 0.250 |
Why?
|
Host-Pathogen Interactions | 1 | 2011 | 1516 | 0.230 |
Why?
|
Angiolipoma | 1 | 2021 | 14 | 0.230 |
Why?
|
Down-Regulation | 2 | 2021 | 3226 | 0.220 |
Why?
|
Phosphatidic Acids | 1 | 2021 | 56 | 0.220 |
Why?
|
Transaminases | 1 | 2021 | 225 | 0.210 |
Why?
|
Lung Neoplasms | 2 | 2021 | 12009 | 0.210 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2021 | 205 | 0.200 |
Why?
|
Chloroquine | 1 | 2021 | 275 | 0.200 |
Why?
|
Amiloride | 1 | 2018 | 135 | 0.190 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2021 | 316 | 0.190 |
Why?
|
gamma-Glutamyltransferase | 1 | 2018 | 127 | 0.180 |
Why?
|
Serine | 1 | 2021 | 848 | 0.170 |
Why?
|
Mice, Inbred NOD | 2 | 2021 | 1974 | 0.170 |
Why?
|
Phospholipids | 1 | 2021 | 811 | 0.160 |
Why?
|
Kidney Neoplasms | 4 | 2021 | 4017 | 0.160 |
Why?
|
Dextrans | 1 | 2018 | 626 | 0.160 |
Why?
|
Mice, SCID | 2 | 2021 | 2913 | 0.160 |
Why?
|
Drug Synergism | 1 | 2021 | 1939 | 0.150 |
Why?
|
Cell Proliferation | 4 | 2021 | 10990 | 0.150 |
Why?
|
Lysophosphatidylcholines | 1 | 2015 | 77 | 0.150 |
Why?
|
Cell Line | 3 | 2021 | 17137 | 0.140 |
Why?
|
Antigens, Viral, Tumor | 1 | 2013 | 143 | 0.130 |
Why?
|
Mice, Nude | 1 | 2021 | 4040 | 0.130 |
Why?
|
Tumor Suppressor Proteins | 3 | 2021 | 2902 | 0.120 |
Why?
|
Oligopeptides | 1 | 2018 | 1305 | 0.120 |
Why?
|
Signal Transduction | 4 | 2021 | 24351 | 0.120 |
Why?
|
Polyomavirus Infections | 1 | 2013 | 183 | 0.110 |
Why?
|
Interleukin-6 | 1 | 2021 | 3105 | 0.110 |
Why?
|
RNA-Binding Proteins | 1 | 2021 | 1961 | 0.110 |
Why?
|
Animals | 9 | 2021 | 170849 | 0.110 |
Why?
|
Mice | 7 | 2021 | 80803 | 0.110 |
Why?
|
Tumor Virus Infections | 1 | 2013 | 451 | 0.110 |
Why?
|
Rats, Inbred F344 | 1 | 2011 | 897 | 0.100 |
Why?
|
Flow Cytometry | 1 | 2021 | 6230 | 0.100 |
Why?
|
Stilbenes | 1 | 2011 | 212 | 0.100 |
Why?
|
Fibroblasts | 1 | 2021 | 4345 | 0.100 |
Why?
|
Cell Line, Transformed | 1 | 2011 | 1026 | 0.100 |
Why?
|
NIH 3T3 Cells | 1 | 2011 | 723 | 0.100 |
Why?
|
Up-Regulation | 1 | 2018 | 4441 | 0.090 |
Why?
|
Carcinoma, Renal Cell | 2 | 2021 | 2911 | 0.080 |
Why?
|
Gene Expression | 1 | 2021 | 8182 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2017 | 3006 | 0.080 |
Why?
|
DNA Replication | 1 | 2013 | 1490 | 0.080 |
Why?
|
Cytomegalovirus Infections | 1 | 2011 | 721 | 0.080 |
Why?
|
Lipid Metabolism | 1 | 2015 | 1995 | 0.080 |
Why?
|
Homeostasis | 1 | 2017 | 3297 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3972 | 0.070 |
Why?
|
HeLa Cells | 2 | 2021 | 3395 | 0.070 |
Why?
|
Neoplasm Metastasis | 1 | 2015 | 5391 | 0.060 |
Why?
|
Virus Replication | 1 | 2011 | 2589 | 0.060 |
Why?
|
Transfection | 1 | 2011 | 6329 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5252 | 0.060 |
Why?
|
Phosphoserine | 1 | 2021 | 220 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2021 | 4416 | 0.050 |
Why?
|
Histamine | 1 | 2021 | 525 | 0.050 |
Why?
|
Angiomyolipoma | 1 | 2021 | 196 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2015 | 13898 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2010 | 3053 | 0.050 |
Why?
|
Rats | 2 | 2015 | 25307 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2015 | 8610 | 0.040 |
Why?
|
Sterol Regulatory Element Binding Proteins | 1 | 2015 | 29 | 0.040 |
Why?
|
Phospholipases A2 | 1 | 2015 | 210 | 0.040 |
Why?
|
Protein Transport | 1 | 2021 | 2101 | 0.040 |
Why?
|
Naphthyridines | 1 | 2015 | 124 | 0.040 |
Why?
|
Neoplasms | 2 | 2015 | 19538 | 0.030 |
Why?
|
Humans | 11 | 2021 | 686663 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2011 | 20620 | 0.030 |
Why?
|
Anaphase | 1 | 2013 | 122 | 0.030 |
Why?
|
Simian virus 40 | 1 | 2013 | 321 | 0.030 |
Why?
|
Chromosomal Instability | 1 | 2013 | 158 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2021 | 15597 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 23439 | 0.030 |
Why?
|
Kinetochores | 1 | 2013 | 196 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2021 | 3092 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2021 | 17251 | 0.030 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2015 | 778 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2011 | 406 | 0.030 |
Why?
|
Stereoisomerism | 1 | 2011 | 709 | 0.030 |
Why?
|
Phosphorylation | 1 | 2021 | 8896 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 17071 | 0.020 |
Why?
|
Female | 4 | 2021 | 375459 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2015 | 1178 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2011 | 777 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2021 | 4716 | 0.020 |
Why?
|
Mitosis | 1 | 2013 | 1276 | 0.020 |
Why?
|
Sirolimus | 1 | 2015 | 1605 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2015 | 2304 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2018 | 3190 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2021 | 8130 | 0.020 |
Why?
|
Molecular Structure | 1 | 2011 | 2072 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2011 | 2103 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2015 | 2103 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2021 | 13469 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2011 | 3313 | 0.020 |
Why?
|
DNA Damage | 1 | 2013 | 2507 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2015 | 2297 | 0.020 |
Why?
|
Chromatin | 1 | 2013 | 2503 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2011 | 6835 | 0.010 |
Why?
|
Cell Cycle | 1 | 2011 | 3066 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 12680 | 0.010 |
Why?
|
Models, Molecular | 1 | 2011 | 5778 | 0.010 |
Why?
|
Computational Biology | 1 | 2011 | 3612 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 11616 | 0.010 |
Why?
|
Computer Simulation | 1 | 2011 | 6120 | 0.010 |
Why?
|
Male | 2 | 2021 | 352465 | 0.010 |
Why?
|